Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition resulting
from chemotherapy for cancer. Severe acute CIPN may require chemotherapy dose …

Background The majority of breast cancer patients use complementary and/or integrative
therapies during and beyond cancer treatment to manage symptoms, prevent toxicities, and …

Chemotherapy-induced peripheral neuropathic pain (CIPNP)—a severe adverse effect
observed in up to 80% of patients during treatment with antineoplastic drugs—limits the …

The US population of cancer survivors age≥ 65 years will continue to grow rapidly over the
next few decades. This growth will be driven largely by the aging of the national population …

Cancer and its treatment exert a heavy psychological and physical toll. Of the myriad
symptoms which result, pain is common, encountered in between 30% and 60% of cancer …

Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect
of platinum drugs, the mechanisms of this toxicity remain unknown. Previous work in our …

Chemotherapy‐induced peripheral neurotoxicity (CIPN) is one of the most frequent and
severe long‐term side effects of cancer chemotherapy. Preclinical and clinical studies have …

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious
complications associated with anticancer drugs. CIPN leads to a lower quality of life and …

Highlights•Ketamine is an established dissociative anesthetic.•Ketamine's primary action
involves inhibition of N-methyl-D-aspartate (NMDA) receptors.•Ketamine also modulates …

Nursing Knowledge, Practice Patterns, and Learning Preferences Regarding Chemotherapy-Induced
Peripheral Neuropathy Page 1 Oncology Nursing Forum • Vol. 41, No. 6, November 2014 669 …